Novel Difluorocyclohexyl Derivatives As IL-17 Modulators for Treating Inflammatory and Autoimmune Diseases
Overview
Overview
Journal
ACS Med Chem Lett
Publisher
American Chemical Society
Specialty
Chemistry
Date
2022 Feb 18
PMID
35178169
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Tang X, Wang C, Wang L, Ren F, Kuang R, Li Z Acta Pharm Sin B. 2023; 13(9):3930-3944.
PMID: 37719372 PMC: 10501871. DOI: 10.1016/j.apsb.2023.03.017.
Sabnis R ACS Med Chem Lett. 2023; 14(5):553-554.
PMID: 37197462 PMC: 10184153. DOI: 10.1021/acsmedchemlett.3c00139.
References
1.
Stober C
. Pathogenesis of psoriatic arthritis. Best Pract Res Clin Rheumatol. 2021; 35(2):101694.
DOI: 10.1016/j.berh.2021.101694.
View
2.
Griffiths C, Armstrong A, Gudjonsson J, Barker J
. Psoriasis. Lancet. 2021; 397(10281):1301-1315.
DOI: 10.1016/S0140-6736(20)32549-6.
View
3.
Ghoreschi K, Balato A, Enerback C, Sabat R
. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021; 397(10275):754-766.
DOI: 10.1016/S0140-6736(21)00184-7.
View
4.
W Marson J, Snyder M, Lebwohl M
. Newer Therapies in Psoriasis. Med Clin North Am. 2021; 105(4):627-641.
DOI: 10.1016/j.mcna.2021.04.004.
View
5.
Loft N, Halling A, Egeberg A, Skov L
. Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysis. J Am Acad Dermatol. 2020; 84(1):130-138.
DOI: 10.1016/j.jaad.2020.07.085.
View